Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE3
Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency
- Status
- COMPLETED
- Phase
- NA
Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1, Dose-Escalation Study of IGN002 in NHL Subjects
- Status
- TERMINATED
- Phase
- PHASE1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents
- Status
- COMPLETED
- Phase
- NA
Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies
- Status
- COMPLETED
- Phase
- NA
Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A
- Status
- COMPLETED
- Phase
- PHASE3
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
- Status
- RECRUITING
- Phase
- PHASE2
Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Carfilzomib Plus Belinostat in Relapsed/Refractory NHL
- Status
- COMPLETED
- Phase
- PHASE1
Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
- Status
- COMPLETED
- Phase
- PHASE2